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Abstract
Background: Inferring gene-to-phenotype and gene-to-human disease model relationships from annotated mouse
phenotypes and disease associations is critical when researching gene function and identifying candidate disease
genes. Filtering the various kinds of genotypes to determine which phenotypes are caused by a mutation in a
particular gene can be a laborious and time-consuming process.
Methods: At Mouse Genome Informatics (MGI, www.informatics.jax.org), we have developed a gene annotation
derivation algorithm that computes gene-to-phenotype and gene-to-disease annotations from our existing
corpus of annotations to genotypes. This algorithm differentiates between simple genotypes with causative
mutations in a single gene and more complex genotypes where mutations in multiple genes may contribute
to the phenotype. As part of the process, alleles functioning as tools (e.g., reporters, recombinases) are filtered out.
Results: Using this algorithm derived gene-to-phenotype and gene-to-disease annotations were created for 16,000
and 2100 mouse markers, respectively, starting from over 57,900 and 4800 genotypes with at least one phenotype and
disease annotation, respectively.
Conclusions: Implementation of this algorithm provides consistent and accurate gene annotations across MGI and
provides a vital time-savings relative to manual annotation by curators.
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Background
Genetic mutations in mouse models have proven a
valuable tool in investigating gene function and facili-
tating research into human disease. The phenotypes as-
sociated with these mutations in mice occur in the
context of other defined or undefined mutations in
their genome. To determine if a phenotype is caused by
a mutation in a specific gene, providing insight into
gene function, the impact of each allele in the genotype
needs to be evaluated. Doing this manually is a labori-
ous and time-consuming process. Intensely researched
genes may have dozens of alleles each with multiple
genotypes. The mouse gene Pax6 (MGI:97490) alone
has 53 mutant alleles present in some 150 mouse geno-
types with phenotype annotations in Mouse Genome
Informatics (MGI, as of 12/29/2015). Only a fraction of
these reported phenotypes are caused solely by the mu-
tation(s) in Pax6.
MGI (www.informatics.jax.org) provides gold-standard
annotations to describe mouse models in the context of
both the known alleles and strain backgrounds of the
mice [1]. In MGI, phenotype and disease annotations are
ascribed to a genetic representation (allele pairs and
strain background) of the mice that displayed the pheno-
type. Sophisticated genetic engineering techniques have
allowed for the production of multi-genic models with
spatiotemporal control of gene expression and the intro-
duction of multi-color reporters. These increasingly
complex models may include both causative mutations
and non-causative transgenic tools [2]. To relate pheno-
type and disease annotations made to a genotype in
MGI with the gene, genomic marker, or transgene con-
taining the causative mutation, non-causative markers,
such as transgenic tools (e.g., recombinases and* Correspondence: susan.bello@jax.org
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reporters), need to be computationally excluded from
consideration. For example, mice carrying an inducible
knock-in of a mutant form of mouse Kcnj11 in the
Gt(ROSA)26Sor locus and a transgene expressing cre
recombinase in pancreatic cells, Tg(Ins2-cre)23Herr
(genotype MGI:4430413), are annotated to the Mam-
malian Phenotype ontology (MP) [3] term ‘decreased
insulin secretion’ (MP:0003059) and are a model of per-
manent neonatal diabetes mellitus (OMIM:606176) [4].
The phenotype and disease annotations are correctly asso-
ciated with Kcnj11. However, the annotations should not
be linked with the cre recombinase transgene or
Gt(ROSA)26Sor since neither directly causes the phe-
notypes or disease displayed by the mice.
MGI is implementing improvements throughout the
database to enhance the ability of users to evaluate the
function of genes. As part of this, phenotype and disease
associations at the level of the gene are now being pre-
sented (see below) in multiple locations in the MGI web-
site. The gene-level associations give users an overview
of the phenotypes and diseases associated with a gene
that can be challenging to decipher from detailed model
annotations. For both phenotypes and disease, creating a
gene-level annotation implies that mutations in this gene
cause the associated phenotype or disease. Therefore,
the gene-level annotations may be useful to identify can-
didate genes for specific phenotypes and/or diseases. To
create these gene-level associations, we have developed
rules to algorithmically identify and computationally
separate causative mutations from transgenic tools in
complex mouse genotypes.
The first and simplest implementation of the rules ex-
cluded all complex genotypes and removed recombinase
and wild-type alleles prior to inferring relationships. The
need to separate causative mutations from transgene
tools can best be illustrated by example. The complex
genotype Apoetm1Unc/ Apoetm1Unc Faslgld/Faslgld on an in-
bred C57BL/6 strain genetic background (MGI:5514345)
is annotated to the human disease Systemic Lupus Ery-
thematosus, SLE (OMIM:152700) [5]. Inferring a causal
relationship between Apoe and/or Fasl and SLE may or
may not be correct, since it is unclear whether one or
both genes are responsible for the observed phenotype.
For complex genotypes such as this one, the algorithm
does not derive any gene annotations. Conversely,
Smotm1Amc/Smotm2Amc Isl1tm1(cre)Sev/Isl1+ mice on a mixed
129 strain genetic background (MGI:3689403) are anno-
tated to the phenotype ‘perinatal lethality’ (MP:0002081)
[6]. The Isl1 recombinase allele is present to drive dele-
tion of the loxP-flanked Smo allele in the cardiovascular
system; thus, we do not want to associate the perinatal
lethality phenotype with Isl1. As we can clearly identify
the non-causative allele and distill this genotype to
alleles associated to a single gene, we derive a
relationship between the phenotype ‘perinatal lethality’
and the gene Smo.
Other databases presenting phenotype and disease an-
notations for model organisms also have to decide when
an annotation to a model can used to infer information
about gene function. For example, the Zebrafish Model
Organism Database (ZFIN, www.zfin.org, [7]) annotates
phenotypes to a fish line that includes the alleles, trans-
genes and/or morpholinos used in an experimental co-
hort. Each allele and morpholino has an asserted
relationship to a gene. Gene level annotations are then
inferred for lines where only 1 asserted gene relationship
exists (Y. Bradford, personal communication). Gene level
annotations are not inferred for fish with more than one
asserted gene relationship or for fish expressing non-
reporter transgenes. This is similar to the early stages of
the MGI algorithm. A key difference between mouse
and zebrafish models, for the purpose of inferring gene
annotations, is the widespread use of knock-in mutations
in mouse where asserting the gene to allele relationship
is less straightforward.
In contrast to the restrictive approach taken by ZFIN
and MGI, the Monarch Initiative (monarchinitiati-
ve.org, [8]), which integrates data from both MGI and
ZFIN as well as many other sources, infers gene anno-
tations for all genes in a model. Thus, in the example
above (Apoetm1Unc/ Apoetm1Unc Faslgld/Faslgld) gene an-
notations would be inferred for both Apoe and Fasl
(M. Brush, personal communication). This approach
maximizes the number of gene-to-phenotype annota-
tions but means the user will need to evaluate the re-
sults to remove false positive associations.
In the current implementation, presented below, the
algorithm we have developed excludes additional trans-
genic tools, accounts for the introduction of expressed
genes in alleles, and deals with multi-genic mutations.
This approach increases the number of derived gene an-
notations, while attempting to reduce both the number
of false positive and false negative annotations. While
the precise implementation would not be of use to other
databases the logic behind the algorithm should be
transferable.
Gene annotation derivation rules
Refinement of the derivation rules to eliminate add-
itional types of transgenic tools has been an iterative
process. Various changes to the MGI database schema
have facilitated the identification and removal of many
types of transgenic tools and non-causative marker asso-
ciations. Throughout this process we have worked to
minimize the number of false positive associations. The
overall goal of these rules is to eliminate transgenic tools
alleles and then infer gene, multi-genic marker, or trans-
gene relationships from genotypes with only a single
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remaining associated locus. Genotypes with multiple as-
sociated loci are not used to infer gene relationships, with a
few exceptions (see below). Recent re-implementation of
these rules in a consistent manner across all MGI products
has improved the gene annotation data quality at the dis-
play level and allowed us to make this data set available for
export.
Details of the annotation derivation rules
In the application of the derivation rules, genotypes are
processed in a step-by-step fashion (see Fig. 1). First,
the number of genetic loci associated with all alleles in
the genotype is determined (Fig. 1, box 1). Genetic loci
include: genes within the mutation region, genes
expressed by the allele, transgene markers, and pheno-
typic markers. For example, the alleles Apptm1Dbo,
Tg(tetO-Notch4*)1Rwng, and Del(7Coro1a-Spn)1Dolm
(MGI:2136847, MGI:4431198, MGI:5569506 respectively)
are associated with one, two, and forty loci, respectively.
The two loci associated with Tg(tetO-Notch4*)1Rwng are
the transgene itself and the expressed mouse gene, Notch4.
The forty loci associated with Del(7Coro1a-Spn)1Dolm
include the deletion region itself (recorded in MGI as
a single, unique genetic marker) and all thirty nine
endogenous mouse genes overlapping the deletion region.
Gene-to-phenotype and gene-to-disease annotations can
then be derived for the genes in nearly all genotypes with
a single associated genetic locus (see docking sites below
for the exception).
For genotypes including more than one locus, such as
those described above, non-causative alleles are identi-
fied and computationally excluded from consideration.
Non-causative allele types in the algorithm include:
transgenic transactivator alleles, transgenic reporter al-
leles, knock-in and transgenic recombinase alleles, and
wild-type alleles. Since many knock-in transactivator and
reporter alleles may also be knock-out alleles that are
causative for a phenotype, only transgenic alleles of these
types are excluded. For recombinase alleles, curation in
MGI distinguishes between conditional genotypes,
where these alleles function as a recombinase, and non-
conditional genotypes, where these alleles may be
causative; therefore, both transgenic and knock-in re-
combinase alleles may be eliminated when the genotype
is conditional. When the genotype is not conditional,
recombinase alleles are retained. For a recombinase or
transactivator allele to be excluded, it must express only
a single gene. In cases where another gene is expressed,
the allele is retained. For example the recombinase al-
lele Tg(Tyr-cre/ERT2)1Lru (MGI:3617509) is excluded
at this stage, so no derived annotation to the transgene
is computed as a result of this allele. But the allele
Tg(Tyr-cre/ERT,-Hras1*,-Trap1a)10BJvde
(MGI:4354013) is retained, as it expresses both Hras1
and Trap1a in addition to cre. Additional rules de-
scribed below address whether and how to derive anno-
tations to those genes. Motifs (ERT2, ERT) designed to
alter the expression of cre are not curated as expressed
genes and are therefore ignored by the algorithm.
After excluding non-causative alleles, the number of
remaining loci is determined for each genotype. Gene-
to-phenotype and gene-to-disease annotations are then
derived for genes and genomic markers in genotypes
with a single remaining locus. For genotypes with more
than one remaining locus, further processing is done to
identify additional cases where gene annotations can be
derived. If the genotype is associated with a single multi-
genic marker (e.g., Del(7Coro1a-Spn)1Dolm) and one or
more affected genes located in the region, then annota-
tions are derived for the multi-genic marker and not for
the individual endogenous genes in the region (Fig. 1,
box 4). Genotypes associated with more than one multi-
genic mutation or with a multi-genic marker and any
markers outside the mutation region are excluded and
Fig. 1 Flow chart for the application of gene annotation derivation
rules. One gene*, annotations are derived only for certain cases of
genotypes containing a single gene. See text for additional details.
Transgene+, gene annotations are made to the transgene and an
endogenous mouse gene
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annotations are not derived for any of the genes or gen-
omic markers involved.
The number of inserted expressed genes is then con-
sidered. Inserted expressed genes are genes that have
been introduced into the mouse genome and the gene
product is expressed in one or more tissues of the
mouse. Genotypes with multiple associated markers and
no inserted expressed genes are eliminated. Genotypes
associated with multiple inserted expressed genes are as-
sociated to the transgenic locus only, if there is a single
transgene associated with the genotype and no add-
itional endogenous genes (Fig. 1, box 6). In this case, it
is assumed that the transgene is expressing all of the
inserted expressed genes and that the transgene as a
whole, not the individual expressed genes, is causative
for the phenotypes or diseases annotated to the geno-
type. For these genotypes, transgene-to-phenotype and
transgene-to-disease annotations are derived. Derived
annotations are not created for the inserted expressed
genes. Other genotypes having more than one inserted
expressed gene are excluded and no gene or transgene
annotations are derived.
Genotypes associated with only a single inserted
expressed gene (Fig. 1, box 7) are divided into two
types: those expressing a mouse gene and those ex-
pressing a non-mouse gene. Genotypes associated with
an expressed non-mouse gene are eliminated. No as-
sumption is made that the phenotypes or diseases dis-
played would also be produced if the orthologous
mouse gene had been used instead. Gene-to-phenotype
and gene-to-disease annotations may be derived for a
transgene and also an endogenous mouse gene in two
cases: 1) if the genotype contains only a single transgene
which carries a single inserted expressed mouse gene
(Fig. 1, box 8); 2) if the transgene, inserted expressed
mouse gene, and the single endogenous gene that is the
same as the inserted expressed mouse gene are associated
with the genotype (Fig. 1, box 9). In both cases annota-
tions are derived for both the endogenous mouse gene
and the transgene (Fig. 1, “transgene + ”).
Three genes (Gt(ROSA)26Sor, Col1a1, Hprt) are com-
monly used, based on examination of alleles in MGI, as
‘docking sites’ in mouse to knock-in expressed genes,
frequently under the control of a heterologous pro-
moter sequence. For example, of the 63 alleles of
Col1a1 in MGI with the attribute “inserted expressed
sequence”, 55 have a construct inserted in the untrans-
lated region based on the molecular description in MGI
(12/7/15). For genotypes associated with a docking site
and a single expressed mouse gene, gene-to-phenotype
and gene-to-disease annotations are derived for the
expressed gene and not for the docking site. There are
no known phenotypes or diseases ascribed to mutations
in Gt(ROSA)26Sor (MGI:104735, [9]). Therefore, no
derived annotations are created for Gt(ROSA)26Sor, even
when there are no associated expressed genes in MGI.
MGI currently only annotates expressed genes with an
ortholog in mouse; therefore, not all Gt(ROSA)26Sor
alleles with an inserted expressed gene have an as-
sociated expressed gene. For example the allele
Gt(ROSA)26Sortm1(gp80,EGFP)Eces (MGI:5004724) expresses
a gene from the Kaposi sarcoma herpes virus that does
not have an ortholog in mouse. The phenotypes displayed
by mice carrying this allele are the result of expression of
the viral gene but as there is no display in MGI for any
gene-to-phenotype annotations for a viral gene with no
mouse ortholog, no derived annotations are created. In-
sertions in Col1a1 (MGI:88467) and Hprt (MGI:96217)
are typically made without altering normal endogenous
gene function. For Col1a1 and Hprt alleles, annotations
are derived for the inserted expressed gene when one is
present. If no expressed genes are present then
annotations are derived for the docking site gene itself
(Fig. 1, box 10).
The final case where gene annotations are derived is
when the inserted expressed mouse gene is identical to
the endogenous gene (Fig. 1, box 11). No gene annota-
tions are created for any remaining genotypes.
Gene annotation derivation examples
To illustrate the function of the derivation algorithm, four
example genotypes have been overlayed on the flow chart
(Fig. 2). For mice hemizygous for Tg(tetO-Notch4*)1Rwng
and Tg(Tek-tTA)1Rwng (genotype MGI:5502689, Fig. 2a),
the transactivator expressing transgene Tg(Tek-tTA)1Rwng
is excluded from consideration. This leaves 2 remaining
genes, Tg(tetO-Notch4*)1Rwng and Notch4. As this leaves a
single transgene marker and a single expressed mouse
gene, gene level annotions are derived for both the
transgene and the expressed mouse gene. For mice homozy-
gous for Prnptm1Cwe and Tg(Prnp*D177N*M128V)A21Rchi
(genotype MGI:3836994, Fig. 2b) there are no non-causative
alleles to remove. The single transgene in this case expresses
the same mouse gene that is mutated by the allele
Prnptm1Cwe leaving the genotype associated with two genes,
mouse Prnp and Tg(Prnp*D177N*M128V)A21Rchi. As this
fits the requirements for the transgene exception (Fig. 2, box
9) annotations are derived for both the endogenous mouse
gene and the transgene. For mice heterozygous for the
deletion Del(7Coro1a-Spn)1Dolm and hemizygous for
the reporter transgene Tg(Drd2-EGFP)S118Gsat (genotype
MGI:5571091, Fig. 2c), the reporter transgene is excluded
from consideration. As the deletion marker is associated
with the 39 genes in the deletion region, this genotype falls
into the Phenotypic mutation class for purposes of the algo-
rithm. Gene annotations are derived for the deletion marker
but not for the 39 genes in the deletion region (Fig. 2c, box
4). Mice heterozygous for Ewsr1tm2(FLI1*)Sblee and hemizygous
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Fig. 2 (See legend on next page.)
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for Tg(CAG-cre/Esr1*)5Amc (genotype MGI:4429149,
Fig. 2d) illustrate a case where gene annotations are not
derived. While two non-causative alleles are removed by
the algorithm, the cre transgene and wild-type allele of
Ewsr1, after processing is complete there are still two
genes associated with the genotype, Ewsr1 and FLI1. As
the gene knocked into Ewsr1 is not a mouse gene this
genotyope is excluded at box 7 in the flow chart. Even if
the expressed gene had been a mouse gene this genotype
would have been excluded as the expressed gene is not
the same as the mutated endogenous gene.
Output of the rules
Once all genotypes with phenotype or disease annota-
tions have been processed by the derivation rules the set
of derived gene annotations are used throughout MGI,
HMDC and MouseMine. As currently implemented, the
rules result in derived gene-to-phenotype and gene-to-
disease annotations for over 16,000 and 2200 mouse
markers, respectively, starting from over 57,000 and
4800 genotypes with at least one phenotype and disease
annotation, respectively (as of 1/4/2016). Of the over
57,000 genotypes processed, almost 40,000 contain only
mutations in a single marker (Table 1). Gene level anno-
tations could be derived from these genotypes using the
simplest possible rule (only derive annotations when
there is one marker associated with the genotype). Use
of the derivation algorithm allows a further almost 8000
genotypes to be processed and marker level annotations
created. This represents an almost 14 % increase in the
number of genotypes contributing phenotype annota-
tions at the marker level. Of the approximately 18,000
multiple marker genotypes, conditional genotypes and
genotypes involving alleles expressing inserted genes are
two important subsets. Conditional genotypes are
primarily processed by removal of recombinase alleles.
There are currently over 7000 genotypes where a recom-
binase allele is removed (Table 2). The ability to include
special and temporal specific phenotypes in the gene
level annotations enhances the overall picture of gene
function MGI provides to users. There are over 3700 al-
leles (knock-in and transgenes) expressing at least one
inserted sequence involved in nearly 4800 genotypes
currently in MGI (as of 12/28/15). Over 2000 of these al-
leles express a mouse gene and may therefore potentially
contribute to gene level annotations. Incorporation of these
overexpression and misexpression induced phenotypes
improves both the overall picture of gene function and the
relation of mouse models of human disease to genes.
There is a potential for the creation of false positive
and false negative annotations by the derivation algo-
rithm. One possible source of false positive annotations
is the use of expressed gene relationships to identify
when an allele is expressing a transcript that may alter
the phenotype. For example, the gene Col1a1 has 64 tar-
geted alleles with the attribute “inserted expressed se-
quence” of these 58 have an association to an expressed
gene. Of the remaining 6 alleles, 5 are alleles where an
interfering RNA (RNAi) has been inserted into the gene.
Determining how to represent the relationship between
an RNAi expressing allele and the gene targeted by the
RNAi is one of MGI’s future projects. During the devel-
opment of the algorithm the use of the “inserted
expressed sequence” attribute was still in development
so the presence of an association to an expressed gene
was used. We are reviewing the possibility of changing
the algorithm to use the presence of the “inserted
expressed attribute” instead of the presence of an
expressed gene association, as this would improve our
handling of these cases.
(See figure on previous page.)
Fig. 2 Overlay of specific genotype examples on the flow chart of the gene annotation derivation rules. a Processing of a genotype that results
in annotations to a transgene and endogenous mouse gene. b Processing of a genotype that fits the transgene exception rule, where the
transgene expresses a mouse gene and the same endogenous mouse gene is mutated in the mice. c Processing of a genotype with a reporter
transgene and phenotypic mutation affecting multiple genes. d Processing of a conditional genotype where no gene annotations can be derived
Table 1 Number of genotype and gene annotations processed
by the derivation algorithm
Genotypes with MP and/
or OMIM annotations
Number of genotypes






47,869 (82.6 %) 16,044
One Marker Genotypes
(Fig. 1, box 1)
39,873 (68.9 %) 14,074
Resolved Multiple Marker
Genotypes
7996 (13.8 %) 3870 (1970
novel markers)
Table 2 Breakdown of resolved multiple marker genotypes.
These numbers only include genotypes with MP or OMIM




processed (as of 1/4/2016)
Number
Alleles
Recombinase allelesa 7,015 936
Reporter transgenes 256 157
Transactivator transgenes 282 84
Wild-type alleles 5,371 1,577
aOnly counting recombinase alleles in conditional genotypes which have
MP/OMIM annotations
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One possible source of false negative annotations is
the limitation of “docking site” alleles to only Col1a1,
Hprt and Gt(ROSA)26Sor. For example, annotations
from the genotype MGI:5544092 could be associated
with the mouse gene Edn2 if the marker for the inter-
genic insertion site in the allele Igs1tm11(CAG-Bgeo,-Edn2)Nat
was excluded from consideration. Instead of expanding
the list of markers used for docking sites, we are explor-
ing implementation of a “Docking Site” attribute that
could be applied to specific alleles. This would avoid the
need to modify the algorithm when new docking sites
are encountered but would require back annotation of
existing alleles. Another source of false negative annota-
tions is the use of reporter genes that are a mouse gene
or with an ortholog in mouse. For example, there are 63
knock-in alleles that use the mouse gene Tyr as a coat
color reporter. Other than the pigmentation phenotype,
phenotypes in these mice are the result of the mutated
endogenous locus and not due to the expression of Tyr.
However, using the current algorithm gene annotations
are not derived for any of the annotated phenotypes.
Correcting these would require modifying the algorithm
to both ignore Tyr and teasing apart the phenotypes due
to the reporter from those due to the mutated endogen-
ous locus.
Impact of MGI improvements
The development of these rules has relied heavily on the
implementation of other database improvements in
MGI. For example, the introduction of allele attributes
allowed a distinction to be made between reporter trans-
genes that express only a reporter and transgenes that
express a reporter and some other gene. The attributes
were introduced as part of a restructuring of allele types
into generation method and attributes. Attributes in-
clude both changes to the endogenous gene function
(null/knockout, hypomorph) and characteristics of the
inserted sequence (reporter, recombinase). Some attri-
butes may apply to either the endogenous gene or the
inserted sequence (hypomorph, modified isoform). An
allele may have zero to many attributes but only one
generation method. Certain attributes were then incor-
porated into the rules. These attributes include: reporter,
recombinase, transactivator, and inserted expressed se-
quence. For example, exclusion of a reporter transgene
requires the allele to have the generation method “trans-
genic” and the attribute “reporter” but not the attribute
“inserted expressed sequence”. Therefore, the reporter
transgene Tg(Cspg4-DsRed.T1)1Akik (MGI:3796063)
that has only the attribute “reporter” is excluded as a
non-causative allele. However, the reporter transgene
Tg(CAG-Bmpr1a*,-lacZ)1Nobs (MGI:5473821) has mul-
tiple attributes including “reporter” and “inserted expressed
sequence” and is retained.
The recent introduction of formalized data associa-
tions between transgenic and knock-in alleles and the
genes expressed by these alleles has also been incorpo-
rated into the rules. MGI now annotates alleles express-
ing either a mouse gene or gene with a mouse ortholog
to the gene being expressed. Alleles expressing inserted
genes are then displayed on both the detail page for the
endogenous locus where the insertion occurred and on
the detail page for the mouse gene or mouse ortholog of
the inserted gene being expressed. The rules make use
of these associations to avoid assigning phenotypes to
the endogenous gene in cases where an inserted expressed
gene may be causative. They also allow annotations for
phenotypes and diseases caused by transgenes expressing
a mouse gene to be derived for the expressed mouse
gene. For example, phenotypes for the knock-in allele
Ctnnb1tm1(Nfkbia)Rsu (MGI:3039783) may be the result of
loss of expression of Ctnnb1 or the expression of Nfkbia
and therefore no derived annotations are created. How-
ever, phenotype and disease annotations for the transgene
Tg(Prnp*D177N*M128V)A21Rchi (MGI:3836986) are as-
sumed to be the result of the expression of the mouse
Prnp gene and derived annotations may be created for
both the transgene and the expressed mouse gene.
Use of the derived annotations in MGI
Implementation of the annotation derivation rules de-
scribed here has improved both searching and display of
gene-to-phenotype and gene-to-disease annotations in
MGI. Gene level annotations are used on multiple dis-
plays and by multiple search tools in MGI. These dis-
plays and tools provide users with different ways to
access, group, and filter the data. Regardless of how the
user accesses the data, consistent results sets are now
returned when searching for genes by a phenotype or
disease.
One way a user may access the derived annotations
for a gene or set of genes is using the Human-Mouse:
Disease Connection (HMDC, www.diseasemodels.org,
Fig. 3). In the HMDC, searches for mouse data are re-
stricted to only the derived gene-to-phenotype and
gene-to-disease annotations. In the results, users may
also access the set of genotype annotations used to gen-
erate the gene annotations, but multi-genic genotypes
are excluded from the display. In MGI, the display of a
mouse gene on a disease detail page is based both on
the derived gene-to-disease annotations and on orthol-
ogy relationships to known human disease genes. A
gene that has both a derived gene-to-disease annotation
and is orthologous to a known human disease gene is dis-
played in the human and mouse section of the page.
Those without an orthology relationship but with a de-
rived annotation are shown in the mouse only section. A
similar division is made on the all models page for a
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disease, with multi-genic models that have neither gene
orthologs nor derived annotations shown in the additional
complex models section. The derived gene annotations
are also incorporated into the updated design of the MGI
gene detail page. With this modification, users see a sum-
mary graphic of the types of phenotypes caused by mu-
tations in the gene (Fig. 4). On both the gene detail
page and in the HMDC, gene level annotations are
shown at the MP system level. Users may click through
to see the detailed MP terms and associated allele pairs.
This avoids the problem of displaying conflicting phe-
notypes (i.e., increased vs decreased body weight) at the
gene level. From both locations users can access details
and references to follow up on annotations of interest.
The Genes & Markers Query Form uses the derived
annotations when a user searches by phenotype or
disease to determine the set of genes and markers
returned. The Batch Query tool uses the derived anno-
tations to determine the set of phenotype terms
returned for a gene. In this case, unlike in the HMDC,
the details link includes both the genotypes used to de-
rive the annotations and complex genotypes annotated
to the same term or to a subclass of that term. The
Gene Expression Database (GXD) Query Form uses the
Fig. 3 Display of derived gene-to-phenotype and gene-to-human disease annotations in the HMDC. A search was done for the genes Apc, App,
Erbb2, Fig4 and Kcnj11. Each row shows the derived gene-to-phenotype and gene-to-disease annotations for a mouse gene (in blue). Direct
annotations of human genes to disease (in orange) are shown in the same row as the homologous mouse gene. Results have been filtered to
reduce the number of rows and columns
Fig. 4 Display of derived gene-to-phenotype annotations on the Shh gene detail page in MGI. All Mammalian Phenotype system-level terms are
shown. Blue boxes indicate abnormal phenotypes have been reported for that system. Blank boxes indicate absence of data for Shh mutants in
that system in MGI
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derived annotations to define a set of genes associated
with a phenotype or disease. Users can then retrieve ex-
pression data for the genes in the set. MGI FTP reports
for gene-to-phenotype and gene-to-disease associations
(HMD_HumanPhenotype.rpt and MGI_OMIM.rpt) in-
clude only the derived annotations. Finally, MouseMine
(www.mousemine.org [10]) makes use of the same set
of rules and allows users to trace back to the alleles and
genotypes underlying the derived annotation set. The
connection to the source alleles allows users to filter
the phenotypes based on allele attributes to find, for ex-
ample, phenotypes for a gene caused by null mutations.
Other searches in MGI, such as the Quick Search and
Phenotypes, Alleles & Disease Models Search, return the
set of alleles for a phenotype or disease term and include
annotations for both single- and multi-genic genotypes.
Since these queries return alleles rather than genes, the
rules for the derived annotations are not applied.
The return and display of gene-to-phenotype and
gene-to-disease annotations are critical to evaluation
and comparison of genes and disease models. In the
HMDC, the gene level annotations allow users to refine
a set of genes based on the phenotypes or diseases
resulting from mutations in the gene before delving into
the specifics of the models. On a disease detail page,
users can identify disease models associated with mouse
genes that are orthologous to known human disease
genes and those that are not. The latter class provides a
valuable source of potential new candidate human dis-
ease genes. With the Batch Query tool, a user can re-
trieve all phenotypes and diseases associated with a gene
that can be exported for further analysis. The summary
graphic on the gene detail page will allow users to rap-
idly review and compare the phenotype profiles of genes.
Discussion
The use of rules to derive annotations has two major
advantages over direct curation. First is the hands-on
curatorial time-savings benefit. Curators need to enter
only the genotype-to-phenotype or genotype-to-disease
annotations and do not need to also annotate the gene
relationships. Given the large number of existing anno-
tations and the ongoing need to focus curation efforts
to newly published literature, the elimination of the re-
quirement for manual curation of gene relationships is
vital. Second, using the rules insures consistency of anno-
tation. While we strive for inter-curator consistency at
MGI, some variability is inevitable. With the use of unified
rules, the derived annotations are always consistent.
Despite the advantages of the derived annotation rules,
a limitation of the use of rules to derive annotations as
opposed to direct curation of these relationships is the
loss of some potential annotations. One way annotations
may be lost is due to failure to exclude non-causative al-
leles. For example, knock-in transactivator alleles cannot
currently be excluded. Thus, no derived annotations can
be made for mice with the genotype Foxg1tm1(tTA)Lai/
Foxg1+, Tg(tetO-Gsx2,-EGFP)1Kcam/0 (MGI:4412090).
Further, cases where a reporter gene is a mouse gene or
has an ortholog in mouse (e.g., mouse Tyr, human ALPP)
are captured in the count of expressed genes, but rarely
do these genes contribute to a disease phenotype, when
one is displayed. With modifications to MGI annotations
and additional refinements to the rules we may be able
to eliminate more of these allele types from gene rela-
tionship consideration, through automated processing.
The use of these rules currently also limits the derived
annotations to only those caused by a single gene. The
inclusion of disease and phenotype annotations that rely
on the presence of mutations in multiple genes are com-
pletely excluded by the current algorithm. So gene-to-
phenotype annotations are not created for either gene
based on annotations for mice homozygous for both
Epn1tm1Ocr and Epn2tm1Ocr (MGI:4356019), where the
phenotypes are the result of combined loss of both genes
and loss of either gene alone does not produce an abnor-
mal phenotype[11]. While it would be possible in such a
case to ascribe all phenotypes from the double homozy-
gote to both genes, the situation is frequently more
complex. In many cases, only some of the phenotypes
displayed are caused by the double mutation while
others are caused by only one of the mutations. Thus,
decisions may need to be made at the individual Mam-
malian Phenotype term annotation level and not at the
level of the genotype. In addition the potential for differ-
ences in strain background and annotation depth be-
tween genotypes to create false positive associations is
increased relative to annotations inferred for genotypes
with a single causative gene. For example, a subsequent
paper looking at the impact of loss of expression of both
Epn1 and Epn2 in the vasculature on tumor develop-
ment [12] did not include either single homozygote as a
control making it difficult to determine conclusively
that loss of both genes is required for the phenotype.
Similarly, mice homozygous for mutations in both
Cd80 and Cd86 (MGI:3620124) have been reported to
be a model for Insulin-Dependent Diabetes Mellitus
(OMIM:222100) but single homozygotes were not ex-
amined and the strain background is different from that
reported previously for the single homozygotes [13]. In
this case, it is likely the mutations in Cd80 and Cd86
modify the disease phenotype but do not cause the dis-
ease as the mutations were moved into a strain (NOD)
known to develop diabetes. Due to these issues and
questions of how to distinguish multi-genic from
monogenic phenotypes in the web display, attempting
to distinguish between causal mutations, modifying
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mutations and annotation gaps for multi-genic geno-
types was determined to be beyond the scope of the
current algorithm.
Clarity of display also drove the decision to infer only
gene-to-phenotype and gene-to-disease annotations for
expressed mouse genes and not for expressed orthologs
of mouse genes. Inferring a gene-to-disease relationship
to the mouse gene for phenotypes in mice heterozygous
for Col1a1tm1(CAG-IDH2*R140Q)Kkw (MGI:5582197) [14]
would have resulted in the display of the mouse gene
Idh2 on the disease detail page for D-2-Hydroxyglutaric
Aciduria 2 (OMIM:613657), giving the impression that
the mouse gene has been used to model the disease
when it is the human gene being expressed. However,
since the species of the ortholog is currently stored in
the database, future implementations of the MGI disease
displays could use this information by, for example, pro-
viding links to humanized mouse models of a disease.
Another focus for improvement of the algorithm is the
reduction of the number of remaining false-positive de-
rived annotations. One source of false positives is geno-
types where the strain background is responsible for the
phenotype or disease displayed. In Mora et al. [15], mice
homozygous for Selltm1Flv on a congenic NOD back-
ground (MGI:3039435) were generated to investigate the
effect of loss of Sell expression on insulin dependent dia-
betes (OMIM:222100). These mice show the same dia-
betic phenotype as wild-type NOD controls. However,
the rules derive an annotation of Sell to diabetes based
on the annotation of this genotype to this OMIM term.
Refinements to MGI annotations and incorporation of
strain background information into the derivation rules
may allow us to exclude these genes from the results sets
in the future.
Conclusion
The conversion of gene-to-phenotype and gene-to-dis-
ease relationships in MGI from several variable rules
used only for web page display to a single set of well-
defined rules used to create derived annotations in the
database improves both the consistency and accessibil-
ity of these relationships, as well as facilitates easier
modifications to the rules. The derived gene-to-
phenotype and gene-to-disease annotations are used for
web display, downloads, and public reports and are
available for export. Consumers of the exported data
need to be aware of the restrictions placed on the anno-
tations by the algorithm as this may alter interpreta-
tions of the data. Changes made to the rules can be
seen throughout the database after any data update.
The increased adaptability of these rules will aid our abil-
ity to keep pace with the changes in transgenic technology
in the future.
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